Literature DB >> 32722659

Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls.

Jan Nowacki1, Katja Wingenfeld1, Michael Kaczmarczyk1, Woo Ri Chae1, Ikram Abu-Tir1, Christian Eric Deuter1, Dominique Piber1, Julian Hellmann-Regen1, Christian Otte2.   

Abstract

Mineralocorticoid receptors (MR) are predominantly expressed in the hippocampus and prefrontal cortex. Both brain areas are associated with social cognition, which includes cognitive empathy (ability to understand others' emotions) and emotional empathy (ability to empathize with another person). MR stimulation improves memory and executive functioning in patients with major depressive disorder (MDD) and healthy controls, and leads to glutamate-mediated N-methyl-D-aspartate receptor (NMDA-R) signaling. We examined whether the beneficial effects of MR stimulation can be extended to social cognition (empathy), and whether DCS would have additional beneficial effects. In this double-blind placebo-controlled single-dose study, we randomized 116 unmedicated MDD patients (mean age 34 years, 78% women) and 116 age-, sex-, and education years-matched healthy controls to four conditions: MR stimulation (fludrocortisone (0.4 mg) + placebo), NMDA-R stimulation (placebo + D-cycloserine (250 mg)), MR and NMDA-R stimulation (both drugs), or placebo. Cognitive and emotional empathy were assessed by the Multifaceted Empathy Test. The study was registered on clinicaltrials.gov (NCT03062150). MR stimulation increased cognitive empathy across groups, whereas NMDA-R stimulation decreased cognitive empathy in MDD patients only. Independent of receptor stimulation, cognitive empathy did not differ between groups. Emotional empathy was not affected by MR or NMDA-R stimulation. However, MDD patients showed decreased emotional empathy compared with controls but, according to exploratory analyses, only for positive emotions. We conclude that MR stimulation has beneficial effects on cognitive empathy in MDD patients and healthy controls, whereas NMDA-R stimulation decreased cognitive empathy in MDD patients. It appears that MR rather than NMDA-R are potential treatment targets to modulate cognitive empathy in MDD.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32722659      PMCID: PMC7785026          DOI: 10.1038/s41386-020-0777-x

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

1.  A systematic review of the impact of social cognitive deficits on psychosocial functioning in major depressive disorder and opportunities for therapeutic intervention.

Authors:  Michael James Weightman; Matthew James Knight; Bernhard Theodor Baune
Journal:  Psychiatry Res       Date:  2019-02-18       Impact factor: 3.222

2.  Cognitive function following a major depressive episode: a systematic review and meta-analysis.

Authors:  Maria Semkovska; Lisa Quinlivan; Tara O'Grady; Rebecca Johnson; Aisling Collins; Jessica O'Connor; Hannah Knittle; Elayne Ahern; Taylor Gload
Journal:  Lancet Psychiatry       Date:  2019-08-15       Impact factor: 27.083

Review 3.  Neural mechanisms of the cognitive model of depression.

Authors:  Seth G Disner; Christopher G Beevers; Emily A P Haigh; Aaron T Beck
Journal:  Nat Rev Neurosci       Date:  2011-07-06       Impact factor: 34.870

4.  Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.

Authors:  Christian Otte; Steffen Moritz; Alexander Yassouridis; Maike Koop; Ana Maria Madrischewski; Klaus Wiedemann; Michael Kellner
Journal:  Neuropsychopharmacology       Date:  2006-10-11       Impact factor: 7.853

5.  Cognitive impairment in major depression: association with salivary cortisol.

Authors:  Kim Hinkelmann; Steffen Moritz; Johannes Botzenhardt; Kirsten Riedesel; Klaus Wiedemann; Michael Kellner; Christian Otte
Journal:  Biol Psychiatry       Date:  2009-08-26       Impact factor: 13.382

Review 6.  Cognitive Adaptation under Stress: A Case for the Mineralocorticoid Receptor.

Authors:  Susanne Vogel; Guillén Fernández; Marian Joëls; Lars Schwabe
Journal:  Trends Cogn Sci       Date:  2016-01-20       Impact factor: 20.229

Review 7.  Mineralocorticoid receptor function and cognition in health and disease.

Authors:  Katja Wingenfeld; Christian Otte
Journal:  Psychoneuroendocrinology       Date:  2018-09-15       Impact factor: 4.905

Review 8.  Top-down and bottom-up control of stress-coping.

Authors:  Edo R de Kloet; Sybren F de Kloet; Carien S de Kloet; Annette D de Kloet
Journal:  J Neuroendocrinol       Date:  2019-02-01       Impact factor: 3.627

9.  Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans.

Authors:  Ulrike Rimmele; Luciana Besedovsky; Tanja Lange; Jan Born
Journal:  Neuropsychopharmacology       Date:  2012-12-06       Impact factor: 7.853

10.  HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.

Authors:  J Keller; R Gomez; G Williams; A Lembke; L Lazzeroni; G M Murphy; A F Schatzberg
Journal:  Mol Psychiatry       Date:  2016-08-16       Impact factor: 15.992

View more
  2 in total

1.  Potential biomarkers: differentially expressed proteins of the extrinsic coagulation pathway in plasma samples from patients with depression.

Authors:  Chunyue Yu; Teli Zhang; Shanshan Shi; Taiming Wei; Qi Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Brain mineralocorticoid receptor in health and disease: From molecular signalling to cognitive and emotional function.

Authors:  Susana N Paul; Katja Wingenfeld; Christian Otte; Onno C Meijer
Journal:  Br J Pharmacol       Date:  2022-04-07       Impact factor: 9.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.